Sightera Biosciences
🇧🇪 Antwerp, Belgium · Founded 2024 · 1-10 employees
Patient-derived AI drug discovery platform based in Antwerp. Sightera Biosciences is a healthtech and deeptech startup based in Antwerp, Belgium, founded 2024, with $3.2M raised to date.
Sightera Biosciences is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.
Total raised
$3.2M
Business model
SaaS
Key differentiator
Sightera uniquely integrates complex patient-derived preclinical models (SPAR technology) with AI to generate small molecules optimized for specific patient populations, rather than relying on traditional single-target discovery.
Target customer
Pharmaceutical and biotechnology companies
Sectors
Key investors
Entourage, Anacura, QBIC
Notable achievements
- Raised €3 million in a pre-seed round led by Entourage, Anacura, and QBIC
- Spin-off from the University of Antwerp and Antwerp University Hospital (UZA)
- Advancing molecular-glue oncology program SIGHT001 toward a preclinical candidate
Frequently asked questions
- What does Sightera Biosciences do?
- Patient-derived AI drug discovery platform based in Antwerp.
- Where is Sightera Biosciences based?
- Sightera Biosciences is based in Antwerp, Belgium, founded in 2024.
- How much has Sightera Biosciences raised?
- Sightera Biosciences has raised $3.2M in tracked funding.
- Who has invested in Sightera Biosciences?
- Investors in Sightera Biosciences include Entourage, Anacura and QBIC.